Peer Review History
| Original SubmissionSeptember 8, 2025 |
|---|
|
PONE-D-25-48736Evaluation of optical quality in a Fresnel-structured hyperopic implantable collamer lenses using ray-tracing simulationPLOS One Dear Dr. Kawamorita, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Amit Kumar Goyal, PhD Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Some of the reviewers have suggested to include more literature. Authors are free to cite or not cite the mentioned references. This will not impact the decision process. Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting paper about reducing the thickness of a hyperopic implantable lens, but it would be worth reworking the examples to see if the image quality improves if the phase delay at the steps is forced to be an integral number of wavelengths. L73. A concern is raised at this introductory text in the paper, because a diffractive lens is not the same as the type of “Fresnel lens” discussed here. A diffractive lens has zone boundaries that match a specific equation, with light from all the zones interfering at specific image distances that are linked by the zone boundary equation. The text here should be modified. Fresnel was involved with both lighthouse lenses that do not create an image, and diffractive effects, but not actually diffractive lenses. The wording here needs to be clearer, and Fresnel’s observation to do with diffraction was essentially that the phase repeats after every wavelength. Physical distances related to this came to be called “Fresnel zones”, but perhaps not in his lifetime? L100 Conv. ICL. Is this conventional? Would standard be better? Conv. Is odd and not defined? A 3mm entrance pupil is used, rather than an actual internal 3mm pupil, which would be more like an average eye. And only an additional 5 mm entrance pupil is used? The main concern about the current paper relates to the concept described 40 years ago in this paper, and perhaps in other publications also: A "tuned" Fresnel lens. Giovanni Vannucci.15 August 1986 / Vol. 25, No. 16 / APPLIED OPTICS 2831-2834 There is also this patent from 30 years ago: United States Patent. Silberman. 5,178,636. 1993. TUNED FRESNEL LENS FOR MULTIFOCAL INTRAOCULAR APPLICATIONS INCLUDINGSMALL INCISION SURGERIES. Donn M. Silberman, Iolab Corporation, Claremont, Calif. A recent paper that includes a discussion about diffractive lenses is the following: Design concepts for advanced-technology intraocular lenses [Invited]," Biomed. Opt. Express 16, 334 (2025). https://doi.org/10.1364/BOE.544647. There may also be other papers that discuss Fresnel lenses and pay attention to the zone boundary locations, and the phase delays at the steps. Discussions online and in the literature are often muddled about the notion of a “Fresnel lens”. The examples in the paper have different steps in microns, and with a 50 micron step, the phase delay for a material index of 1.46 is about 10.5 waves, which means that light from one zone would destructively interfere with light from the next. A single wavelength is delayed by 0.546/(1.45-1.336), or wavelength/(index1-index2). The other physical steps have other delays. So the fundamental question about this ICL paper is what the calculations would look like if the phase delay at each step was an integral number of wavelengths. In principle, the wavefront would then be similar to the situation with no steps at all, at the design wavelength (though the steps are high, and at an angle there would be some effect from the steps themselves). It just seems like this should be explored before this paper is published. Reviewer #2: 1. The study relies almost exclusively on MTF analysis at a single wavelength (555 nm). While MTF is an important indicator of optical quality, it does not fully capture clinically relevant visual phenomena such as stray light, halo formation, glare, or contrast sensitivity under polychromatic conditions. The authors are strongly encouraged to extend the analysis to include additional optical quality metrics (e.g., point spread function, Strehl ratio, stray light simulation, or polychromatic MTF) to better support the claimed clinical relevance. 2. The Fresnel structure inherently introduces discontinuities that may generate diffraction effects and stray light, particularly at step edges. However, the simulations were conducted only in sequential ray-tracing mode. A non-sequential optical analysis incorporating scattering or edge diffraction effects is essential to realistically evaluate potential photic phenomena, especially given the discussion on halos and glare in hyperopic ICLs. 3. All simulations are based on a single Liou & Brennan model eye with fixed biometric parameters. Inter-individual variability in anterior chamber depth, pupil decentration, α-angle, and pupil eccentricity is not considered. A sensitivity or tolerance analysis examining the robustness of the Fresnel ICL performance under realistic anatomical variations would substantially strengthen the generalizability of the conclusions. 4. Although multiple step heights (25–100 µm) were evaluated, the rationale for selecting these specific values is not sufficiently justified from a manufacturing, biomechanical, or clinical standpoint. The manuscript would benefit from a clearer explanation of how these step heights relate to practical fabrication limits, long-term mechanical stability, and potential biological interactions within the eye. 5. The study is entirely simulation-based, and the designed conventional ICL is described as a “pseudo-model.” Without optical bench validation or experimental comparison using fabricated Fresnel structures, it is difficult to assess how well the simulation results translate to real optical performance. At minimum, the limitations of relying solely on numerical simulations should be discussed more explicitly, along with a clearer roadmap for experimental validation. 6. While the simulation results suggest improved or maintained optical performance, the manuscript occasionally implies near-clinical readiness of the Fresnel hyperopic ICL. Given the absence of experimental data, patient variability analysis, and stray-light evaluation, these claims should be tempered. The authors should more clearly distinguish between theoretical optical feasibility and clinical applicability, revising the Discussion and Conclusion accordingly. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Evaluation of optical quality in a Fresnel-structured hyperopic implantable collamer lenses using ray-tracing simulation PONE-D-25-48736R1 Dear Dr. Kawamorita, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Amit Kumar Goyal, PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-48736R1 PLOS One Dear Dr. Kawamorita, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Amit Kumar Goyal Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .